Task: Answer the MCQ question.
Query: Which drug exhibits a -28.165% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CC1=NC(C(F)(F)F)(C(F)(F)F)C2=C(CC(C)(C)CC2=O)N1Cc1ccco1
[b] O=C(CCC(=O)c1ccc(Cl)s1)Nc1ncccc1O
Answer: b. O=C(CCC(=O)c1ccc(Cl)s1)Nc1ncccc1O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCC(=O)c1ccc(Cl)s1)Nc1ncccc1O
O=C(CCC(=O)c1ccc(Cl)s1)Nc1ncccc1O
4-(5-chlorothiophen-2-yl)-N-(3-hydroxypyridin-2-yl)-4-oxobutanamide